This is the first evidence of a survival benefit with a chemotherapy-free targeted therapy regimen in BRAF V600E-mutant colorectal cancer, say reserachers.
Medscape Medical News
Original Article: BEACON Lights Way for Chemo-Free Therapy in Colorectal Cancer